Advertisement Fidelity
Home > Boards > US OTC > Biotechs >

CTD Holdings Inc. (CTDH)

Add CTDH Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator AceSpades, ZachBuffett
Search This Board:
Last Post: 4/17/2014 4:44:35 PM - Followers: 92 - Board type: Free - Posts Today: 0





CTD Holdings, Inc.

14120 NW 126th Terrace
Alachua, FL 32615

Phone: 386-418-8060

 & &




Company Info:


CTD Holdings, Inc. engages in the marketing and sale of cyclodextrins and related products. The company develops cyclodextrins-based applications in stabilization of flavors for food products; preparation of antifungal complexes for foods and toiletries; elimination of undesirable tastes and odors; stabilization of fragrances and dyes; reduction of foaming in foods; cosmetics and toiletries; and the improvement of quality, stability, and storability of foods. It also manufactures selected cyclodextrin complexes, as well as distributes cyclodextrins. CTD Holdings sell cyclodextrins, the molecules that bring oil and water together for applications in the areas of agriculture, analytical chemistry, biotechnology, cosmetics, diagnostics, electronics, foodstuffs, pharmaceuticals, and toxic waste treatment. In addition, the company provides consulting services for the commercialization of new products containing cyclodextrins, as well as sells own manufactured and licensed products containing cyclodextrins. It serves chemical supply houses, pharmaceutical companies, diagnostics companies, and food companies for research and development. The company was founded in 1990 and is based in High Springs, Florida.



Share Structure:


As of March 3, 2014:

100,000,000  Shares Authorized

48,562,355 Issued and Outstanding
Source:  March 3, 2014 10-K Filing

Insider Holdings - April 14, 2014
r  and (Page 8)
33,187,647 (19,837,647 accounted for on SEC Form 4s - - CE Rick Strattan

Public Float Estimated Float (April 14, 2014):
15,374,708 (31.65%)




YouTube Videos - Great updates regularly released directly from CTD Holdings:

CTD Holdings March 2014 Update Video
March 14, 2014 -

CTD Holdings Private Placement Update
February 21, 2014 -

CTD Holdings February 2014 Update Video
February 18, 2014 -

CTD Holdings January 2104 Update Video
January 21, 2014 -

CTD Holdings December 2013 Update Video
December 21, 2014 -

Older Update Videos Available at:

Dr. Tate has been consistanly posted monthly update videos since 2010.  Great way to see the history of this company.


DD Links:

CTD Holdings Fact Sheet
March 31, 2012 -

WSR Equity Research Report
February 21, 2012 -

CTD Holdings - Nanosonic Uses USDA Grant to Install Solar Energy System
October 19, 2011 -

FDA Orphan Drug Status Designation - Trappsol
May 17, 2010 -

Dateline Story on Addi & Cassi Hempel - Using Trappsol to Treat Niemann Pick Type C
January 5, 201
0 -


Cyclodextrin As A Therapeutic "Drug" For HIV AIDS, Niemann Pick Type C and other Viruses

April 16th, 2009 -


Mentioned in a Wall Street Journal Article:


Cyclodextrin - Wikipedia:


CEO Rick Strattan - Personally thanked following FDA Approval:


Trappsol Google Search Results:


Cyclodextrin in the News:



 What is a Cyclodextrin?

CDs are molecules that bring together oil and water and have potential applications anywhere oil and water must be used together. Successful applications have been made in the areas of agriculture, analytical chemistry, biotechnology, cosmetics, diagnostics, electronics, foodstuffs, pharmaceuticals and toxic waste treatment. Stabilization of food flavors and fragrances is the largest current worldwide market for CD applications. We and others have developed CD-based applications in stabilization of flavors for food products; elimination of undesirable tastes and odors; preparation of antifungal complexes for foods and toiletries; stabilization of fragrances and dyes; reduction of foaming in foods; cosmetics and toiletries; and the improvement of quality, stability and storability of foods.

CDs can improve the solubility and stability of a wide range of drugs. Many promising drug compounds are unusable or have serious side effects because they are either too unstable or too insoluble in water. Strategies for administering currently approved compounds involve injection of formulations requiring pH adjustment and/or the use of organic solvents. The result is frequently painful, irritating, or damaging to the patient. These side effects can be ameliorated by CDs. CDs also have many potential uses in drug delivery for topical applications to the eyes and skin.
We believe the application of CDs in both over the counter (OTC) and ethical ophthalmic products provides the quickest path to market for the introduction of preparations containing CDs for topical drug use.

Cyclodextrin Market:

CDs have been used in a variety of food products in Japan for over 25 years. In 1999, the economic impact of CDs on the Japanese economy was reported to be $2.6 billion. Within the last 10 years, many more European countries have approved the use of CDs in food products. In the United States, major starch companies are renewing their earlier interest in CDs as food additives. We believe the food additive industry world-wide will continue to increase its use of CDs.
Natural CDs have been confirmed to be generally recognized as safe ("GRAS") in most of the world, now including the U.S. Moreover, recent approvals of products containing CDs by the U.S. Food and Drug Administration ("FDA") suggest that regulatory approval for new products may be easier in the future. In 2001, Janssen Pharmaceutica, now a subsidiary of Johnson & Johnson, received FDA approval to market Sporanox®, an antifungal which contained hydroxypropyl BCD. In 2008, one of our clients used our product, Trappsol® HPB, in an FDA approved compassionate use clinical trial for the treatment of Niemann Pick Type C disease. We now sell this product under our Trappsol® product line as "Cyclo™."  Our customer applied to the FDA to designate Trappsol® Cyclo™ as an orphan drug in the treatment of Niemann Pick Type C disease.  Under the Orphan Drug Act, companies that develop a drug for a disorder affecting fewer than 200,000 people in the United States may seek designation as an orphan drug and, if such application is approved, they have the ability to sell it without competition for seven years, and may get clinical trial tax incentives.  On May 17, 2010, the FDA designated Trappsol® Cyclo™ as an orphan drug for the treatment of Niemann Pick Type C (NPC) disease.
Applications of CDs in personal products and for industrial uses have appeared in many patents and patent applications. Procter & Gamble uses CDs in Bounce®, a popular fabric softener and Febreze®. Avon uses CDs in its dermal preparations using its Age Protective System (APS®). The prices of the natural CDs have decreased enough so that use of these materials will be more price competitive.





Name: C.E. Rick Strattan
Job Title: President and CEO
Phone: (386) 454-0887 ext. 22
Fax: (386) 454-8134

Name: George Fails
Job Title: Director of Field Operations
Phone: (386) 454-0887
Fax: (386) 454-8134

Name: Dr. Jeffrey Tate
Job Title: President/ CEO Nanosonic Products
Phone: (386) 418-8060

Board of Directors:



Latest News Releases:

April 16, 2014
CTD Holdings, Inc. Closes on Securities Purchase and Collaboration Agreement

March 11, 2014
CTD Holdins Reports Record Revenues for 2013

February 20, 2014
CTD Holdings, Inc. Closes on Private Placement



Company Filings:






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTDH News: CTD Holdings, Inc. Closes on Securities Purchase and Collaboration Agreement 04/16/2014 06:00:00 AM
CTDH News: CTD Holdings, Inc. Closes on Securities Purchase and Collaboration Agreement 04/16/2014 06:00:00 AM
CTDH News: CTD Holdings Reports Record Revenues for 2013 03/12/2014 07:00:00 AM
CTDH News: CTD Holdings Reports Record Revenues for 2013 03/12/2014 07:00:00 AM
#4558   Haha. Nice action today. dark knight 04/17/14 04:44:35 PM
#4557   Big buys hitting the ask.....New highs. Let's break into AceSpades 04/17/14 03:52:51 PM
#4556   If memory serves me correct, there was a octagramt 04/17/14 03:45:18 PM
#4555   Info on Directors that have recently been appointed dark knight 04/17/14 12:35:35 PM
#4554   So the next question is what is CTDH AceSpades 04/16/14 10:36:05 PM
#4553   My guess would be it's related to contacts dark knight 04/16/14 06:11:21 PM
#4552   Nice to be updated. Thanks. dark knight 04/16/14 06:08:58 PM
#4551   Ibox updated....if anyone has anything additional they think AceSpades 04/16/14 06:01:10 PM
#4550   UnallowedExistence 04/16/14 03:29:52 PM
#4549   Whats the take.....was the new deal a product AceSpades 04/16/14 01:58:03 PM
#4548   CTDH just got another $1 Million in cash.... AceSpades 04/16/14 11:57:25 AM
#4547   Mark another 52 week high. Liking this trend. ....can't AceSpades 04/14/14 01:49:02 PM
#4546   New 52 week high today. dark knight 04/11/14 01:31:45 PM
#4545   Thanks. I used to be a mod here...ihub AceSpades 04/10/14 04:14:44 PM
#4544   Most of the time I just summarize the ZachBuffett 04/10/14 04:09:49 PM
#4543   Hey Mod - how about some updates to AceSpades 04/10/14 12:17:18 PM
#4542   Yes, this one has been a long wait. octagramt 04/09/14 11:27:26 AM
#4541   I have been adding a little more over was16 04/08/14 07:58:50 PM
#4540   This is a healthy pause. Too much action octagramt 04/08/14 04:56:03 PM
#4539   Still here. This stock is being heavily dark knight 04/08/14 04:53:51 PM
#4538   Hey KS, did I neglect to tell you satelliteguy 04/08/14 04:07:56 PM
#4537   I am so appreciative that this thread is ksuave 04/08/14 03:12:07 PM
#4536   No complaints on the PPS action.....just a statement AceSpades 04/08/14 02:54:58 PM
#4535   Holding in the .30s is preferable to holding ksuave 04/08/14 02:49:17 PM
#4534   Back to silent running..... AceSpades 04/08/14 02:04:15 PM
#4533   Hopefully our seller learned a lesson....if he would AceSpades 04/01/14 11:43:22 AM
#4532   apparently not uw86 03/28/14 03:53:35 PM
#4531   so anything you care to share uw86 03/28/14 02:59:57 PM
#4530   yes I talked to him on a regular basis was16 03/28/14 02:45:34 PM
#4529   anyone talk to dr. tate recently uw86 03/28/14 02:35:07 PM
#4528   I've actually noticed that this stock tends to octagramt 03/27/14 09:08:19 PM
#4527   lazarus let's hope they do something in this uw86 03/27/14 03:36:26 PM
#4526   Lets not forget this UnallowedExistence 03/27/14 03:17:42 PM
#4525   absolutely! and if they dont get on it Lazarus 03/27/14 10:42:01 AM
#4524   Clearly if a legitimate small company like CTDH uw86 03/27/14 09:55:21 AM
#4523   There is no way -- Rick Stratton, CEO Lazarus 03/27/14 09:47:12 AM
#4522   Hey, seriously, if what you are saying is octagramt 03/27/14 04:29:04 AM
#4521 Hydroxypropyl-beta-cyclodextr Lazarus 03/27/14 12:51:34 AM
#4520   Hi John, I think I understand where you octagramt 03/27/14 12:40:10 AM
#4519   I guess we all need to teach our John Bates 03/26/14 10:25:51 PM
#4518   It sounds great, but just to clarify, do John Bates 03/26/14 10:23:08 PM
#4517   Sounds like something they should seriously pursue. If uw86 03/26/14 05:57:36 PM
#4516   You're right, no logic involved. Someone accidentally satelliteguy 03/26/14 05:49:49 PM
#4515   Do they still own that 40 acres??? If Lazarus 03/26/14 05:05:40 PM
#4514   are they giving out free samples of the octagramt 03/26/14 04:56:29 PM
#4513   Yeah, come to think of it based on octagramt 03/26/14 04:31:22 PM
#4512   CTDH is just starting to roll. That Lazarus 03/26/14 04:29:51 PM
#4511   Agreed. Seemed retail to me because the dark knight 03/26/14 04:27:17 PM
#4510   Because of Fear/lack of finesse. Uw86 is correct octagramt 03/26/14 04:07:08 PM
#4509   Thanks DK... appreciate the info. sainte-beuve 03/26/14 04:03:43 PM